IGF1 and prostate carcinoma: Early studies strongly support that periprostatic adipose tissue, particularly under metabolic syndrome-associated inflammation, is a key player in the development of prostate cancer, through the IGF-1 axis, adipokines, and sex hormones (28, 29).